Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Sonographic Evaluation of the Effects of Raloxifene on the Uterus and Ovaries in Premenopausal Patients at High Risk for Developing Breast Cancer

NCT00001837 is registered in ClinicalTrials.gov with National Institutes of Health Clinical Center (CC) as lead sponsor.

NCT NCT00001837
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00001837 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Sonographic Evaluation of the Effects of Raloxifene on the Uterus and Ovaries in Premenopausal Patients at High Risk for Developing Breast Cancer
Lead sponsor
National Institutes of Health Clinical Center (CC)
Phase
Observational
Overall status
Completed
Start date
November 30, 1998
Completion date
October 31, 2005
Enrollment
60
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, breast neoplasm